Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria

Medicine and Dentistry

• Anti-Inflammatory Drug 100%
• Antimalarial Agent 12%
• Antiparasitic Activity 12%
• Artesunate 100%
• Behavioral Change 12%
• Behavioral Treatment 12%
• Brain Areas 12%
• Cerebral Malaria 100%
• Clinical Syndrome 12%
• Cognitive Defect 12%
• Coma 12%
• Cytokine 37%
• Diseases 12%
• Epileptic Seizure 12%
• Erythrocyte 12%
• Frontal Lobe 62%
• Hippocampus 62%
• Infection 37%
• Inflammatory Cytokine 25%
• Interleukin 1 12%
• Interleukin 10 12%
• Interleukin 17 12%
• Interleukin 2 12%
• Interleukin 6 25%
• Malaria 12%
• Malaria Falciparum 12%
• Messenger RNA 25%
• Neurologic Disease 25%
• Pathogenesis 12%
• Plasmodium berghei 25%
• Real-Time Polymerase Chain Reaction 12%
• Single Drug Dose 37%
• Tumor Necrosis Factor 25%

Neuroscience

• Anti-Inflammatory 100%
• Antimalarial Agent 11%
• Artesunate 100%
• Behavioral Treatment 11%
• Brain Areas 11%
• Cognitive Disorders 11%
• Coma 11%
• Cytokine 44%
• Frontal Lobe 55%
• Hippocampus 55%
• Interleukin 1 11%
• Interleukin 10 11%
• Interleukin 17 11%
• Interleukin 2 11%
• Interleukin 6 22%
• Malaria 100%
• Messenger RNA 22%
• Plasmodium falciparum 11%
• Proinflammatory Cytokine 11%
• Real-Time Polymerase Chain Reaction 11%

Immunology and Microbiology

• Antimalarial Agent 11%
• Coma 11%
• Cytokine 33%
• Erythrocyte 11%
• Frontal Cortex 55%
• Hippocampus 55%
• Infection 44%
• Infectious Disease 44%
• Inflammatory Cytokine 11%
• Interleukin 1 11%
• Interleukin 10 11%
• Interleukin 17 11%
• Interleukin 2 11%
• Interleukin 6 22%
• Malaria 100%
• Passive Avoidance Test 11%
• Plasmodium berghei 22%
• Plasmodium falciparum 11%
• Proinflammatory Cytokine 11%
• Real-Time Polymerase Chain Reaction 11%
• Tumor Necrosis Factor 22%